19 Clinical, Medical & Diagnostic Products
Rapid triple-detection test speeds fl u and COVID-19 diagnosis
QuidelOrtho Corporation is broadening its point-of-care diagnostic offerings with the launch of the QUICKVUE Influenza + SARS Test, a CLIA-waived, 510(k)-cleared rapid immunoassay designed for use in physician office laboratories, urgent care centres, emergency departments, pharmacies, and decentralised hospital labs.
The new test provides simultaneous detection and differentiation of influenza A, influenza B, and SARS-CoV-2 antigens from a single patient sample, delivering results in as fast as 10–15 minutes. By helping clinicians quickly distinguish between flu and COVID-19 - two respiratory illnesses with overlapping symptoms - the test supports faster treatment decisions, improved patient outcomes, and reduced community spread.
Designed for professional use, the QUICKVUE Influenza + SARS Test combines an easy-to-collect nasal swab with a streamlined processing workflow and a clear visual readout. Its rapid turnaround and cost-effective design make it an accessible tool for a variety of healthcare settings, without the need for instrument-based testing.
The launch complements QuidelOrtho’s existing SOFIA™ 2 Flu + SARS Antigen FIA platform, offering a visually read option alongside instrument-based testing and reinforcing the company’s leadership in point-of-care respiratory diagnostics. The QUICKVUE Influenza + SARS Test is available across the United States through QuidelOrtho’s established distribution channels.
More information online:
ilmt.co/PL/6D4Y 66040pr@reply-direct.com ADVERTORIAL Biochemistry analyser for glucometer validation and research applications
YSI, a global leader in biochemical analysis solutions, proudly announces the launch of the YSI 2900C Biochemistry Analyzer, the latest advancement in blood glucose measurement and glucometer validation. The 2900C is Class II FDA registered, and designed for use in research, clinical validation, and manufacturing environments where accuracy, speed, and reliability are paramount.
Since introducing the fi rst FDA-registered blood glucose analyser in 1989, the iconic YSI 2300 STAT set the benchmark for glucose measurement. For decades, the 2300 STAT has been considered the gold standard by glucometer manufacturers worldwide. The new YSI 2900C Biochemistry Analyzer builds on this legacy, delivering enhanced performance while maintaining the precision and reliability expected from YSI instruments.
Powered by Immobilised Enzyme Technology (IET), the YSI 2900C Biochemistry Analyzer enables rapid glucose analysis with minimal sample preparation. Users can simply load a sample and receive highly accurate results in approximately 60 seconds.
New app enables remote monitoring of chronic respiratory disease
electronRx, a digital medicine company specialising in pulmonary care, has announced the launch of pDx, a mobile and web- accessible platform that allows patients with chronic respiratory diseases to monitor lung function from home. Compatible with smartphones, tablets, and laptops, pDx provides clinicians with real- time cardiopulmonary data, enabling remote assessment, disease tracking, and tailored treatment adjustments.
The pDx app builds on electronRx’s proprietary purpleDx technology and generates digital biomarkers from device sensors, capturing physiological metrics including heart rate, respiratory rate, and tidal volume. These clinically actionable insights are securely transmitted to healthcare providers through a dedicated dashboard, supporting personalised care and optimising therapeutic outcomes. By reducing the need for frequent hospital visits, pDx helps patients manage conditions such as asthma, COPD, interstitial lung disease, and pulmonary hypertension while easing the burden on healthcare systems.
“pDx represents a meaningful step forward in patient-centred respiratory care,” said Dr Bipin Patel, CEO and Founder, electronRx. “The platform allows continuous monitoring, integrates seamlessly into existing care pathways, and empowers clinicians to make informed decisions while giving patients greater control over their health.”
More information online:
ilmt.co/PL/ZOvQ 66041pr@reply-direct.com
The Spotlight could be on you!
Check out our Media Information Pack for further details and send your Press Releases to
pr@intlabmate.com
Multiparameter measurement
The YSI 2900C Biochemistry Analyzer features a large intuitive touchscreen for simplifi ed operation, integrated autosampler for increased throughput, unique anti-clogging fl uidics design for reduced maintenance, fl exible sampling options (including 96-well plate compatibility, test tube, and syringe sampling), and robust connectivity for easy data integration.
Much like the proven YSI 2900 Series, the YSI 2900C Biochemistry Analyzer is trusted across clinical, food and beverage, and research laboratories. With its advanced features and regulatory approval, it is poised to become the instrument of choice for organisations validating commercial glucometers or conducting glucose research.
More information online:
ilmt.co/PL/1nvm 66035pr@reply-direct.com
redefined GxP-compliant multiparameter device for measurement of up to 4 parameters in parallel
Multifunctional, fully GxP-compliant multimeter that can be operated with pH, ORP, conductivity, oxygen, ISE and turbidity electrodes.
Learn more about our solutions
© 2025 Xylem Inc. or its affiliates. All rights reserved.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44
